Clinical Trial Update: Apalutamide and Leuprolide in Intermediate and High-risk Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating apalutamide with leuprolide in intermediate and high-risk prostate cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Apalutamide (apalutamide)
• Leuprolide (Leuprolide acetate)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-06-21